Company news
Acucort AB news in 2026
Acucort AB's news releases, calls and decks from 2026, newest first.
AcuCort awarded funding from Region Skåne to support its US expansion
September 16, 2026
AcuCort's warrant programme fully subscribed - key personnel to become shareholders in the company
September 1, 2026
AcuCort: AcuCort study on patient preferences published in peer-reviewed scientific journal
August 26, 2026
AcuCort: AcuCort appoints Carl Frisk as Strategic Alliance Manager
August 24, 2026
AcuCort first Phase IV study is now published
August 11, 2026
AcuCort: AcuCort’s first Phase IV study is now published
August 11, 2026
AcuCort granted renewed FDA Small Business Waiver – Important milestone ahead of planned NDA submission in 2026
July 27, 2026
AcuCort: AcuCort granted renewed FDA Small Business Waiver – Important milestone ahead of planned NDA submission in 2026
July 27, 2026
AcuCort: AcuCort publishes newsletter with CEO update
June 17, 2026
AcuCort: AcuCort to attend BIO International Convention in San Diego – focus on strategic partnering discussions
June 11, 2026
AcuCort to attend BIO International Convention in San Diego – focus on strategic partnering discussions
June 11, 2026
AcuCort publishes newsletter with CEO update
April 16, 2026
AcuCort: AcuCort and the FDA agree on iPSP – important step towards US market approval
April 13, 2026
AcuCort and the FDA agree on iPSP - important step towards US market approval
April 13, 2026
AcuCort: AcuCort signs commercial agreement with Glenmark Pharmaceuticals for Germany and five additional European countries
January 22, 2026
AcuCort signs commercial agreement with Glenmark Pharmaceuticals for Germany and five additional European countries
January 22, 2026